Journal of Nuclear Medicine May 2025, jnumed.125.269519; DOI: https://doi.org/10.2967/jnumed.125.269519 ...

Journal of Nuclear Medicine May 2025, jnumed.124.269444; DOI: https://doi.org/10.2967/jnumed.124.269444 ...

Journal of Nuclear Medicine April 2025, jnumed.124.268980; DOI: https://doi.org/10.2967/jnumed.124.268980 ...

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...

Journal of Nuclear Medicine February 2025, jnumed.124.269024; DOI: https://doi.org/10.2967/jnumed.124.269024 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268713; DOI: https://doi.org/10.2967/jnumed.124.268713 ...

Prostate-specific membrane antigen (PSMA) PET was approved by the U.S. Food and Drug Administration in 2020 for the staging of newly diagnosed prostate cancer, yet rates of adoption and real-world ...

Journal of Nuclear Medicine November 2024, jnumed.124.268509; DOI: https://doi.org/10.2967/jnumed.124.268509 ...

Abstract In several malignancies, only a limited number of patients respond to immune checkpoint inhibitors. Predicting and monitoring responses to these inhibitors represent an unmet clinical need.

Implantation of Subcutaneous Tumors FAP-transfected tumor cell lines SK-RC-52.hFAP and CT-26.hFAP were previously generated by lentiviral transduction (33,34).FAP-positive tumor cells were cultured to ...

68 Ga-NC-BCH PET CLDN18.2 gastrointestinal cancers Gastrointestinal cancer is a global disease that seriously endangers human public health. In 2018, gastrointestinal cancers accounted for ...

Fibroblast activation protein (FAP), expressed in the tumor microenvironment of a variety of cancers, has become a target of novel PET tracers. The purpose of this report is to evaluate the imaging ...